Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

BioMarin Pharmaceutical Inc. (BMRN)

86.66   -2.05 (-2.31%) 05-20 16:00
Open: 87.89 Pre. Close: 88.71
High: 87.89 Low: 86.23
Volume: 847,220 Market Cap: 15518M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 87.981 - 88.461 88.461 - 88.859
Low: 85.055 - 85.659 85.659 - 86.161
Close: 85.75 - 86.672 86.672 - 87.437

Technical analysis

as of: 2019-05-20 4:25:42 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 108.40     One year: 126.61
Support: Support1: 84.76    Support2: 79.79
Resistance: Resistance1: 92.81    Resistance2: 108.40
Pivot: 84.32
Moving Average: MA(5): 86.65     MA(20): 84.62
MA(100): 90.26     MA(250): 94.23
MACD: MACD(12,26): -0.39     Signal(9): -1.20
Stochastic oscillator: %K(14,3): 79.08     %D(3): 79.30
RSI: RSI(14): 51.91
52-week: High: 106.74  Low: 79.13  Change(%): -3.0
Average Vol(K): 3-Month: 115341  10-Days: 151557

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
BMRN has closed below upper band by 27.7%. Bollinger Bands are 0.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 16 May 2019 15:24:52 Z
BioMarin (BMRN) in Focus: Stock Moves 7.5% Higher

Wed, 15 May 2019 21:07:52 Z
Noteworthy Wednesday Option Activity: BPMC, BMRN, PGR

Wed, 15 May 2019 20:49:21 Z
Market Close Report: NASDAQ Composite index closes at 7,822.15 up 87.66 points

Thu, 09 May 2019 16:54:51 Z
Sarepta (SRPT) Q1 Earnings Top Estimates, Exondys 51 Sales Up

Thu, 09 May 2019 11:54:52 Z
Analysts Expect QQEW Will Reach $72

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 179.07
Shares Float (M) 177.45
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.480
EPS Est. Current Year -0.740
EPS Est. Next Year -0.240
EPS Est. Next Quarter -0.150
Forward EPS 0.210
Book Value (p.s.) 5.470
PEG Ratio -3.62
Profit Margin -5.99
Operating Margin -10.40
Return on Assets (ttm) -2.0
Return on Equity (ttm) -3.1
Qtrly Rev. Growth 7.3
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 7.85
Levered Free Cash Flow (M) -46.21

Stock Valuations

P/E -180.54
P/E Growth Ratio -0.02
P/BV 15.84
P/S 1814994944.00
P/CF 1976.86

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.